Crossmark

Dextrose prolotherapy at varying concentrations ameliorates tendon injury via IGF-2R: an integrated study of Mendelian randomization and an animal model

Crossref DOI link: https://doi.org/10.1186/s13018-025-05977-9

Published Online: 2025-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Lina

Liang, Hui

Chen, Yulin

Hu, Kai

Liu, Xixia
Funding

Funding for this research was provided by:

the National Natural Science Foundation of Guangxi (2023GXNSFAA026175)

he National Natural Science Foundation of China (81760246)
License Information

Text and Data Mining valid from 2025-06-02

Version of Record valid from 2025-06-02
More Information

Article History

Received: 20 April 2025

Accepted: 28 May 2025

First Online: 2 June 2025

Declarations

:

: This study adhered to the ethical standards for animal experimentation and was approved by the Animal Ethics Committee of Guangxi University of Chinese Medicine (Approval No: DW20240507-129).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below